SUNDAY, DECEMBER 17, 2017

European agency recommends Sanofi Pasteur's Humenza

LYON, France Read More »

Young kids should get new Prevnar, U.S. experts say

Children younger than 5 who already got four doses of Pfizer Inc.'s Prevnar 13 vaccine should get a fifth booster dose of the new version that covers more strains of pneumonia-causing bacteria. Read More »

Researchers' group slams decision to cancel HIV-vaccination facility

The head of an association that represents Canada's HIV researchers is criticizing a federal government decision to scrap plans for an $83.5 million facility that would manufacture potential vaccines. Read More »

Inovio Biomedical to present at DNA Vaccines 2010 Conference

SAN DIEGO Read More »

Genocea Biosciences licenses herpes simplex virus patent estate from university

Genocea Biosciences, a vaccine discovery and development company, announced that it has licensed an extensive patent estate for 25 pending and issued patents related to herpes simplex virus type 2 antigens. Read More »

Texas university gets $40 million grant to make tobacco-based vaccine

The Texas A&M University System and a Texas company have been awarded a $40 million grant from the U.S. Department of Defense to develop vaccines made from tobacco rather than the antiquated egg-based technology. Read More »

2009 H1N1 flu strain will be in next season flu vaccine

The 2009 H1N1 flu virus, which has sickened millions and killed at least 15,000 people worldwide, will be included in the United States Read More »

Novartis receives FDA approval of Menveo

BASEL, Switzerland Read More »

CEL-SCI study shows vaccine blocks progression of rheumatoid arthritis

VIENNA, Va. Read More »

Dutch find no link between infant deaths, vaccine

AMSTERDAM Read More »

Older women not likely to benefit from cervical cancer vaccine

Women older than 40 are unlikely to get much benefit from the vaccine for the virus that causes cervical cancer, a new study reports. Read More »

Single-dose HIV DNA vaccine induces strong immune response in monkeys

For the first time researchers from the U.S. and abroad have shown that a single-dose HIV DNA vaccine can induce a long-lasting HIV-specific immune response in nonhuman primates. Read More »

Dynavax selects clinical candidate in universal flu vaccine program

BERKELEY, Calif. Read More »

WHO says pandemic at less severe end of spectrum: WHO

GENEVA Read More »

NIH, FDA announce initiative to fast-track innovations to public

The U.S. Food and Drug Administration and the National Institutes of Health unveiled an initiative designed to accelerate the process from scientific breakthrough to the availability of new, innovative medical therapies for patients. Read More »

NasVax, Novartis sign vaccine research deal

TEL AVIV Read More »

Cyto Pulse, Karolinska Institutet get clinical trial approval

Cyto Pulse Sciences announced approval from the Swedish Medical Products Agency to conduct a phase I clinical trial evaluating an HIV/DNA vaccine in collaboration with the Karolinska Institutet and the Swedish Institute for Infectious Disease Control. Read More »